EB6_DETAILS

Overwhelming Vote Passes Cornoavirus Relief Bill

03/16/2020 Written by: Megan DiMartino

The U.S. House of Representatives passed the Families First Coronavirus Response Act (the “Act”) in an overwhelming vote on Saturday, March 14, 2020. President Trump has endorsed the legislation and the U.S. Senate is expected to vote on it today.
The Act will be the second emergency Coronavirus response measure to be passed. President Trump had previously signed a bill to provide $8.3 billion in funding to federal health agencies and declared a national emergency this past Friday over the pandemic. A third emergency measure is also being discussed.
Provisions of the Act
In addition to the funding for economic assistance and COVID-19 testing, the Act contains provisions intended to support workers:

  • 14 days of paid sick leave, at two-thirds (or more) of their regular rate of pay, for government workers and employees of companies with fewer than 500 employees. Leave is available to workers who are sick, have to care for a sick family member or have a child whose school or childcare facility has closed due to the Coronavirus.
  • Expansion of the Family and Medical Leave Act (FMLA) for employees of companies with fewer than 500 employees, requiring paid leave at the two-thirds rate after 14 days.
  • A tax credit for employers that provide paid sick leave benefits required by the Act.
  • Additional funding for state unemployment programs.

The Act does not contain a payroll tax suspension that was proposed by President Trump

Healthcare-and-Pharmacy-Navigation-Enhancing-Healthcare-Consumerism
Healthcare and Pharmacy Navigation – Enhancing Healthcare Consumerism
Blog07/22/2025
employee-benefits

As healthcare systems grow more complex, as does the complexity for consumers trying to manage and understand their benefits. Yet many of the systems designed to support them often lack clarity and...

ERISA-PREEMPTION-SUPREME-COURTS-DECISION-ON-PCMA-V-MULREADY-AND-ITS-IMPACT-ON-PBMS
ERISA PREEMPTION: SUPREME COURT'S DECISION ON PCMA V. MULREADY AND ITS IMPACT ON PBMS
Blog07/16/2025
employee-benefits compliance

On June 30, 2025, the U.S. Supreme Court announced its decline to review decision in Pharmaceutical Care Management Association (PCMA) v. Mulready, a ruling by the U.S. Court of Appeals for the 10th...

One-Big-Beautiful-Bill-Act-Passed-What-Happens-Now
One Big Beautiful Bill Act Passed: What Happens Now?
Blog07/09/2025
employee-benefits compliance

Swiftly signed into law on July 4, 2025 by President Trump, after passing through Congress last week, the 900+ page “One Big Beautiful Bill Act” (OBBB) contains a number of provisions which directly...